These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
360 related articles for article (PubMed ID: 2942638)
41. Identification and role of serotonin 5-HT1A and 5-HT1B receptors in primary cultures of rat embryonic rostral raphe nucleus neurons. Héry F; Boulenguez P; Sémont A; Héry M; Becquet D; Faudon M; Deprez P; Fache MP J Neurochem; 1999 May; 72(5):1791-801. PubMed ID: 10217255 [TBL] [Abstract][Full Text] [Related]
42. A comparative autoradiographic study of 5-HT1D binding sites in human and guinea-pig brain using different radioligands. Bruinvels AT; Landwehrmeyer B; Probst A; Palacios JM; Hoyer D Brain Res Mol Brain Res; 1994 Jan; 21(1-2):19-29. PubMed ID: 8164519 [TBL] [Abstract][Full Text] [Related]
43. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor. Tricklebank MD; Neill J; Kidd EJ; Fozard JR Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789 [TBL] [Abstract][Full Text] [Related]
44. Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats. Vergé D; Daval G; Marcinkiewicz M; Patey A; el Mestikawy S; Gozlan H; Hamon M J Neurosci; 1986 Dec; 6(12):3474-82. PubMed ID: 2947981 [TBL] [Abstract][Full Text] [Related]
45. 5.HT1 receptors in the vertebrate brain. Regional distribution examined by autoradiography. Waeber C; Dietl MM; Hoyer D; Palacios JM Naunyn Schmiedebergs Arch Pharmacol; 1989 Nov; 340(5):486-94. PubMed ID: 2533325 [TBL] [Abstract][Full Text] [Related]
46. Agonist action at 5-HT1C receptors facilitates 5-HT1A receptor-mediated spontaneous tail-flicks in the rat. Bervoets K; Millan MJ; Colpaert FC Eur J Pharmacol; 1990 Nov; 191(2):185-95. PubMed ID: 2150818 [TBL] [Abstract][Full Text] [Related]
47. 5-hydroxytryptamine (HT)1A receptors and the tail-flick response. II. High efficacy 5-HT1A agonists attenuate morphine-induced antinociception in mice in a competitive-like manner. Millan MJ; Colpaert FC J Pharmacol Exp Ther; 1991 Mar; 256(3):983-92. PubMed ID: 1672380 [TBL] [Abstract][Full Text] [Related]
48. A pharmacological analysis of the rat spinal cord serotonin (5-HT) autoreceptor. Brown L; Amedro J; Williams G; Smith D Eur J Pharmacol; 1988 Jan; 145(2):163-71. PubMed ID: 2965026 [TBL] [Abstract][Full Text] [Related]
49. [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain. Hall MD; el Mestikawy S; Emerit MB; Pichat L; Hamon M; Gozlan H J Neurochem; 1985 Jun; 44(6):1685-96. PubMed ID: 3157780 [TBL] [Abstract][Full Text] [Related]
50. Differential responsiveness of the rat dorsal and median raphe 5-HT systems to 5-HT1 receptor agonists and p-chloroamphetamine. Blier P; Serrano A; Scatton B Synapse; 1990; 5(2):120-33. PubMed ID: 2137943 [TBL] [Abstract][Full Text] [Related]
51. Selective labeling of 5-HT1A and 5-HT1B binding sites in bovine brain. Peroutka SJ Brain Res; 1985 Sep; 344(1):167-71. PubMed ID: 4041865 [TBL] [Abstract][Full Text] [Related]
52. The effects of a 5-HT1 receptor ligand isapirone (TVX Q 7821) on 5-HT synthesis and the behavioural effects of 5-HT agonists in mice and rats. Goodwin GM; De Souza RJ; Green AR Psychopharmacology (Berl); 1986; 89(3):382-7. PubMed ID: 2941817 [TBL] [Abstract][Full Text] [Related]
53. Modulation of neuronal activity in the hippocampus by 5-hydroxytryptamine and 5-hydroxytryptamine1A selective drugs. Peroutka SJ; Mauk MD; Kocsis JD Neuropharmacology; 1987; 26(2-3):139-46. PubMed ID: 2884586 [TBL] [Abstract][Full Text] [Related]
54. 2-(Alkylamino)tetralin derivatives: interaction with 5-HT1A serotonin binding sites. Naiman N; Lyon RA; Bullock AE; Rydelek LT; Titeler M; Glennon RA J Med Chem; 1989 Jan; 32(1):253-6. PubMed ID: 2521252 [TBL] [Abstract][Full Text] [Related]
55. Pharmacological characterization of release-regulating serotonin autoreceptors in rat cerebellum. Bonanno G; Maura G; Raiteri M Eur J Pharmacol; 1986 Jul; 126(3):317-21. PubMed ID: 2944750 [TBL] [Abstract][Full Text] [Related]
56. Serotonin receptors in brain revisited. Palacios JM Brain Res; 2016 Aug; 1645():46-9. PubMed ID: 26740406 [TBL] [Abstract][Full Text] [Related]
57. 5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis. Sharp T; Bramwell SR; Grahame-Smith DG Br J Pharmacol; 1989 Feb; 96(2):283-90. PubMed ID: 2466516 [TBL] [Abstract][Full Text] [Related]
58. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand. Titeler M; Lyon RA; Davis KH; Glennon RA Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239 [TBL] [Abstract][Full Text] [Related]
59. Solubilization of serotonin1a and serotonin1b binding sites from bovine brain. Asarch KB; Shih JC J Neurochem; 1987 May; 48(5):1494-501. PubMed ID: 2951498 [TBL] [Abstract][Full Text] [Related]
60. [3H]WAY-100635 for 5-HT1A receptor autoradiography in human brain: a comparison with [3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia. Burnet PW; Eastwood SL; Harrison PJ Neurochem Int; 1997 Jun; 30(6):565-74. PubMed ID: 9152998 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]